In late 2025, the American Society of Hematology (ASH) conference highlighted many important updates for people living with Chronic Lymphocytic Leukemia (CLL), including emerging treatment approaches, long-term follow-up on existing therapies, and practical guidance for patient care. Each year, this international meeting brings together blood cancer experts from around the world to share the latest research, clinical trial results, and insights into how these findings may influence care now and in the years ahead.
Several patient-focused organizations have shared webinars, articles, and videos on ASH 2025. A selection of these resources is included below, highlighting key findings and what they may mean for people living with CLL. Together, these updates show that research and patient care in CLL continues to advance, offering more options and hope for those affected.
(Note: Information shared at international medical conferences is educational and may not reflect treatment availability across Canada. Always discuss with your healthcare team how new research may apply to you.)
Patient Power:
Presented in a very understandable way for all patients and caregivers.
Video: Clearer CLL Treatment Choices: New BTK Inhibitors, Degraders, and Expert Updates (Note: best to open using Google Chrome; Firefox browser may not work)
Articles:
– Why This Year’s ASH could Redefine the Future of CLL Treatment
– New Treatment Updates for Fit AML and High-Risk CLL Patients
– Why Secondary Cancer Screenings Matter – Especially if You Have CLL
– Is Visiting an Academic Center Worth it for CLL Care? What Patients Should Know
CLL Global Research Foundation:
Best for those with prior knowledge of CLL and the presentation of clinical trial data.
Virtual Town Hall: ASH 2025 Highlights (30 minute presentation plus Q&A, held January 27).
Find at: https://www.cllglobal.org/new-events-and-happenings/
CLL Society:
Best for those with some prior knowledge of CLL and the presentation of clinical trial data.
Webinar: ASH 2025 Comes to You (90 minutes, held January 14)